Filing Details
- Accession Number:
- 0001213900-20-041200
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-07 06:18:43
- Reporting Period:
- 2020-12-02
- Accepted Time:
- 2020-12-07 06:18:43
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1174940 | Oragenics Inc | OGEN | Pharmaceutical Preparations (2834) | 593410522 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1598384 | Joseph Hernandez | 15 East Putnam Avenue, Suite 363 Greenwich CT 06830 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $.001 Par Value | Disposition | 2020-12-02 | 5,000,000 | $0.41 | 4,200,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- On May 1, 2020, the reporting person received 9,200,000 shares of Oragenics, Inc. through a Stock Purchase Agreement. On December 2, 2020, the reporting person sold 5,000,000 of those shares on the open market at $0.4103 per share for total proceeds of $2,051,445.66, the market price of the common stock on such date.